Form 4: Bausch Health Executive Discloses Routine Share Disposition for Tax Obligations
Insider Transaction Disclosure
A Bausch Health Companies Inc. executive, Aimee J. Lenar, reported a disposition of 22,736 common shares at $6.42 per share to satisfy tax withholding obligations upon the vesting of Restricted Share Units.
Summary
- Aimee J. Lenar, Executive Vice President of US Pharma at Bausch Health Companies Inc. (BHC), reported a transaction on July 15, 2025.
- The transaction involved the disposition of 22,736 common shares, with no par value, at a price of $6.42 per share.
- These shares were withheld by the Issuer to satisfy tax withholding obligations due upon the vesting of Restricted Share Units.
- Following this transaction, Aimee J. Lenar directly beneficially owns 229,927 common shares of Bausch Health Companies Inc.
Sentiment
Score: 5
Explanation: The transaction is a routine, non-discretionary event for tax purposes upon RSU vesting, which is neutral in terms of company performance or executive sentiment.
Positives
- The transaction is a routine tax withholding event upon the vesting of Restricted Share Units, which is a standard compensation practice and indicates the executive's continued equity ownership in the company.
Negatives
- The disposition of shares was non-discretionary, solely to cover tax obligations, and does not reflect a negative outlook or a voluntary sale by the executive.
Future Outlook
This document, an SEC Form 4, is a disclosure of an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing is a standard regulatory disclosure of an insider transaction and does not provide broader industry context or trends. It reflects a routine compensation event within the pharmaceutical industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| EVP, US Pharma | N/A (identified as current) | Aimee J. Lenar (identified as current) | N/A | N/A (no change reported, only current role identified) |
Stakeholder Impact
- Shareholders: The transaction is a routine, non-discretionary disposition of shares for tax purposes and is unlikely to have a significant direct impact on shareholder value or perception.
- Employees: The transaction reflects a standard executive compensation practice (RSU vesting and tax withholding).
Key Dates
| Date | Description |
|---|---|
| 07/15/2025 | Date of earliest transaction (disposition of shares). |
| 07/16/2025 | Date the Form 4 was signed by the attorney-in-fact for the reporting person. |
Keywords
Bausch Health Companies Inc., BHC, SEC Form 4, Insider Transaction, Share Disposition, Tax Withholding, Restricted Share Units, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.